Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,020,755
+$491,175 QoQ
Shares Held
55,500
0.0% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#104
of 328 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSSIAM holds $60,273,303 across 13 Biotechnology names. HRMY ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,879 | $22,789,475 | |
| 2 | RPRX |
Royalty Pharma plc
|
304,236 | $17,058,512 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,821 | $7,471,865 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,350 | $6,453,639 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
40,357 | $2,309,227 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
55,500 | $2,020,755 | |
| 7 | INCY |
Incyte Corp
|
9,109 | $1,032,596 | |
| 8 | MRNA |
Moderna, Inc.
|
12,237 | $856,957 |
All Filings in HRMY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,020,755 | 55,500 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $1,529,580 | 55,500 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||